Behavioral changes seen after sleep learning
Volunteers smoked less after a night of olfactory conditioning. New Weizmann Institute research may bring the idea of sleep learning one step closer to reality. The research, which… read more.
Volunteers smoked less after a night of olfactory conditioning. New Weizmann Institute research may bring the idea of sleep learning one step closer to reality. The research, which… read more.
With research and development costs for many drugs reaching well into the billions, pharmaceutical companies want more than ever to determine whether their drugs already at market have… read more.
Substance abuse assessments needed before drugs are prescribed, researchers say. Teens prescribed anti-anxiety or sleep medications may be up to 12 times more likely to abuse those drugs… read more.
by Esther Drain: A sub-group analysis of the CRYSTAL study. In the CRYSTAL study, adding cetuximab (cet) to first-line chemotherapy (CT) improved clinical outcome in patients (pts) with RAS… read more.
by Denys Wheatley: There is some irony in the title of this symposium because medicine should always be as precise as it can, and advances are expected that… read more.
Professor Lenz gives his opinions following the presentation of data from FIRE 3 and CALGB/SWOG 80405 at ESMO 2014.
Engagement of patients and understanding of early death in this group by Denys Wheatley. (1) When and why do teenage and young adult oncology patients die early in… read more.
by Denis Wheatley: In her introduction, Yolane Lievens (Belgium) explained that when we have to defer from making comment because of the need to be discrete (the Emperor… read more.
Keynote lecture: Professor Sir Mike Stratton (Cambridge/Hinxton, UK) by Denys Wheatley. On the thesis that the genetic understanding of cancer is fundamental to classifying and hence treating patients… read more.
Click ‘Read More’ for the new data delegate views on whether early tumour shrinkage is now an accepted marker in mCRC.
by Denys Wheatley: Chaired by Atsushi Ohtsu and Jean-Yves Douillard, the first speaker Dr Kato (Japan) addressed the issue of the quest for different mutations in the hope… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.